Drug restores kidney cell function in experimental models of rare Lowe syndrome
Over two decades of research into the cellular mechanisms underlying Lowe syndrome have led to the identification of a potential therapeutic strategy for this rare genetic disorder, which affects the eyes, nervous system and kidneys. The findings are described in a study published in Signal Transduction and Targeted Therapy, by the research group led by Antonella De Matteis, coordinator of the…
Read original article on Medical Xpress - latest medical and health news stories →